Gottschalk, S.* ; König, H.H.* ; Weber, A.* ; Leitzmann, M.F.* ; Stein, M.J.* ; Peters, A. ; Flexeder, C. ; Krist, L.* ; Willich, S.N.* ; Nimptsch, K.* ; Pischon, T.* ; Gastell, S.* ; Steindorf, K.* ; Herbolsheimer, F.* ; Ebert, N.* ; Michels, K.B.* ; Dorrn, A.* ; Harth, V.* ; Obi, N.* ; Karch, A.* ; Teismann, H.* ; Völzke, H.* ; Meinke-Franze, C.* ; Klimeck, L.* ; Seum, T.L.* ; Dams, J.*
Costs associated with insufficient physical activity in Germany: Cross-sectional results from the baseline examination of the German national cohort (NAKO).
Eur. J. Health Econ. 26, 117-128 (2024)
Kurz, C.F. ; König, A.
The causal impact of sugar taxes on soft drink sales: Evidence from France and Hungary.
Eur. J. Health Econ. 22, 905-915 (2021)
Kirsch, F. ; Becker, C. ; Schramm, A.* ; Maier, W. ; Leidl, R.
Patients with coronary artery disease after acute myocardial infarction: Effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival.
Eur. J. Health Econ. 21, 607–619 (2020)
Steinbeisser, K. ; Schwarzkopf, L. ; Graessel, E.* ; Seidl, H.
Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: Results from the German randomized controlled DeTaMAKS-trial.
Eur. J. Health Econ. 21, 825–844 (2020)
Krack, G.
How to make value-based health insurance designs more effective? A systematic review and meta-analysis.
Eur. J. Health Econ. 20, 841-856 (2019)
Müller, D.* ; Danner, M.* ; Schmutzler, R.* ; Engel, C.* ; Wassermann, K.* ; Stollenwerk, B. ; Stock, S.* ; Rhiem, K.*
Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer.
Eur. J. Health Econ. 20, 739-750 (2019)
Müller, D.* ; Danner, M.* ; Rhiem, K.* ; Stollenwerk, B. ; Engel, C.* ; Rasche, L.* ; Borsi, L.* ; Schmutzler, R.K.* ; Stock, S.*
Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.
Eur. J. Health Econ. 19, 341–353 (2017)
Stollenwerk, B. ; Welchowski, T. ; Vogl, M. ; Stock, S.*
Cost-of-illness studies based on massive data: A prevalence-based, top-down regression approach.
Eur. J. Health Econ. 17, 235-244 (2016)
Müller, D.J.* ; Stock, S.* ; Stollenwerk, B.
Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes.
Eur. J. Health Econ. 16, 517-527 (2015)
Seidl, H. ; Hunger, M. ; Leidl, R. ; Meisinger, C. ; Wende, R.* ; Kuch, B.* ; Holle, R.
Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: Results from the KORINNA study.
Eur. J. Health Econ. 16, 671-681 (2015)
Vogl, M. ; Leidl, R.
Informing management on the future structure of hospital care: An extrapolation of trends in demand and costs in lung diseases.
Eur. J. Health Econ., DOI: 10.1007/s10198-015-0699-4 (2015)
Fischer, K.E. ; Leidl, R.
Analysing coverage decision-making: Opening Pandora's box?
Eur. J. Health Econ. 15, 899-906 (2014)
Stollenwerk, B. ; Gandjour, A.* ; Lüngen, M.* ; Siebert, U.*
Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.
Eur. J. Health Econ. 14, 1035-1048 (2013)
Haas, L. ; Stargardt, T. ; Schreyögg, J.
Cost-effectiveness of open versus laparoscopic appendectomy: A multilevel approach with propensity score matching.
Eur. J. Health Econ. 13, 549-560 (2012)
Schad, M. ; John, J.
Towards a social discount rate for the economic evaluation of health technologies in Germany: An exploratory analysis.
Eur. J. Health Econ. 13, 127-144 (2012)
Wenig, C.M.
The impact of BMI on direct costs in children and adolescents: Empirical findings for the German Healthcare System based on the KiGGS-study.
Eur. J. Health Econ. 13, 39-50 (2012)
Drummond, M.* ; Jönsson, B.* ; Rutten, F.* ; Stargardt, T.
Reimbursement of pharmaceuticals: Reference pricing versus health technology assessment.
Eur. J. Health Econ. 12, 263-271 (2011)
Schreyögg, J. ; Grabka, M.M.
Copayments for ambulatory care in Germany: A natural experiment using a difference-in-difference approach.
Eur. J. Health Econ. 11, 331-341 (2010)
Stargardt, T.
The impact of reference pricing on switching behaviour and healthcare utilisation: The case of statins in Germany.
Eur. J. Health Econ. 11, 267-277 (2010)
Behrend, C. ; Buchner, F.* ; Happich, M. ; Holle, R. ; Reitmeir, P. ; Wasem, J.*
Risk-adjusted capitation payments: How well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set.
Eur. J. Health Econ. 8, 31-39 (2007)